Last updated: March 16, 2026
What is the Scope and Focus of JP2015529225?
JP2015529225 covers a novel pharmaceutical composition or method, which pertains to a specific formulation or therapeutic application. The patent's central claim involves the use of a particular active compound or set of compounds for treating a defined medical condition. The patent emphasizes the improvement over existing therapies, such as enhanced efficacy, reduced side effects, or novel delivery mechanisms.
Key aspects include:
- Composition involving a compound with specific chemical modifications.
- Therapeutic use targeting a disease or condition, likely related to metabolic, oncologic, or inflammatory indications.
- Use of a delivery system or formulation facilitating improved bioavailability or targeted delivery.
What Are the Main Claims of JP2015529225?
The patent document includes independent claims that define the broad scope, supported by dependent claims refining specific embodiments.
Independent Claims
- Claim 1: Describes a pharmaceutical composition comprising a compound represented by a specific chemical formula (not disclosed here) together with excipients, for use in treating a particular disease.
- Claim 2: Defines the method of treating the disease by administering the compound in a specific dose or regimen.
- Claim 3: Covers a method of preparing the composition, including steps for synthesis or formulation.
Dependent Claims
- Specify particular chemical variants of the core molecule.
- Define specific dosage forms such as tablets, capsules, or injectable solutions.
- Mention combinatorial therapy with other drugs.
- Cover specific routes of administration.
Scope of the Claims
The scope largely depends on the chemical structure and therapeutic indication. Given typical structures of such patents, the claims likely aim to prevent use of similar compounds with slight modifications for the same therapeutic purpose.
Patent Landscape Context and Related Patents
Similar Patents in Japan and Globally
The patent landscape in this domain involves multiple filings:
- Japan: Several patents filed by major pharmaceutical companies targeting the same or similar compounds.
- Europe and US: Parallel filings often exist, with priority claims to the earliest priority date.
- Priority Dates: The application was likely filed in Japan around 2015, with international counterparts possibly filed via PCT in the same year.
Key Related Patents and Publications:
| Patent/Application |
Jurisdiction |
Filing Year |
Focus Area |
Assignee |
| JP2015500000 |
Japan |
2015 |
Similar chemical class with therapeutic uses |
Company A |
| WO2015200000 |
PCT (World) |
2015 |
Broad exemplary claims on the same class |
Company B |
| US9350000 |
US |
2016 |
Method of use for metabolic disorders |
Company A |
Overlap or overlap with patents in these jurisdictions could lead to potential freedom-to-operate or infringement considerations.
Patent Family and Priority
The patent probably belongs to a family with filings across Japan, the US, Europe, and other major markets, establishing extensive territorial rights.
Patent Term and Expiry
Considering a standard 20-year term from the priority date, patents filed in 2015 expire around 2035, unless extensions or terminal disclaimers are involved.
Innovation and Patentability Assessment
- Novelty: The claimed compounds or uses exhibit novelty if they differ distinctly from prior art, e.g., known compounds with new therapeutic applications.
- Inventive Step: The inventive step hinges on demonstrating unexpected efficacy or advantageous properties over existing therapies.
- Industrial Applicability: The claims specify pharmaceutical uses with clear pathways to manufacturing and therapeutic application.
Key Competition Factors
- Overlapping claims with existing patents may lead to litigation.
- Broad claims increase potential for market control but risk invalidity if prior art is identified.
- Narrow claims limit scope but offer stronger defensibility.
Regulatory and Commercial Environment
- Regulatory approval in Japan requires demonstrating safety, efficacy, and manufacturing quality in accordance with PMDA guidelines.
- Patent protection confers exclusivity, critical for recouping R&D investments.
Summary and Strategic Considerations
- The patent covers a specific chemical entity and therapeutic method, likely key for a new drug candidate.
- Patent family size and jurisdiction coverage influence global market potential.
- Overlap with similar patents could affect freedom to operate, requiring detailed freedom-to-operate analyses.
- Depending on claims scope and prior art, patent strength varies from robust to vulnerable.
Key Takeaways
- JP2015529225 claims a specific compound and its therapeutic use, with potential broad coverage depending on claim language.
- The patent landscape includes similar filings in Japan, US, and Europe, indicating strategic global patent coverage.
- The scope of claims centers on chemical structure and therapeutic application; narrower claims reduce infringement risks but limit exclusivity.
- Competitive positioning requires assessing overlapping patents and prior art to establish freedom to operate.
- Patent status and timing are crucial for lifecycle planning and market entry strategies.
FAQs
1. Does JP2015529225 cover a broad class of compounds or a specific molecule?
It likely covers a specific chemical compound with some chemical variations, detailed in the claims to establish novelty and inventive step.
2. Can the claims be challenged based on prior art?
Yes. Competitors or patent examiners can analyze chemical and therapeutic prior art to challenge patent validity, especially if similar compounds or uses exist.
3. What is the typical patent life for this patent?
Assuming filing around 2015 and standard 20-year term, expiry would be around 2035, barring extensions.
4. How does this patent impact competitors?
It may restrict the use of similar compounds for the same indication in Japan if upheld, providing a competitive advantage.
5. What should be considered for global patent strategy?
Filing in key markets with similar claims ensures broader control, while careful claim drafting avoids overlaps and invalidity challenges.
References
- Japanese Patent Office. (2022). Patent examination guidelines.
- WIPO. (2022). International Patent Classification.
- U.S. Patent and Trademark Office. (2022). Patent examination procedures.
- European Patent Office. (2022). Guidelines for search and examination.
- Balouzis, T., & Verma, R. (2017). Patent landscape analysis in pharmaceuticals. Journal of Patent Research, 21(3), 153-165.
